Potential treatment target in fatty liver disease identified
Metabolic dysfunction-associated steatotic liver disease (MASLD) can cause more serious liver conditions, such as liver failure. A new study, led by Lund University in Sweden, presents new data that may lead to better disease ...
Feb 26, 2026
0
0









